|Globalization and access to drugs (WHO/EDM, 1999, 97 p.)|
The authors acknowledge the following individuals who contributed comments and constructive suggestions to the review of this document: D. G. Barboza (Law Firm of Neviani, Borges & Beildeck, Rio de Janeiro); P. Chirac (pharmacist, la revue Prescrire, Paris); C. Correa (Professor at the University of Buenos Aires); M. Haubert (Director of the Institute of Study on Economic and Social Development at the University of Paris I); B. Remiche (Professor at the University of Louvain); as well as F.S. Antezana (Former Deputy Director-General, WHO), and P. Brudon, D. Fresle, H.V. Hogerzeil, J.D. Quick and T. Sodogandji, from the Action Programme on Essential Drugs, WHO.
The authors acknowledge the helpful comments and clarifications received from the Secretariat of the World Trade Organization.
The interest expressed by Member States, multilateral organizations and nongovernmental organizations (NGOs) is also acknowledged.
Note to the reader
This document represents an introduction to the issue and one of many contributions to the on-going process of analysing the pharmaceutical and public health implications of relevant international agreements, including trade agreements. The main text of this revised version of Globalization and access to drugs incorporates the helpful comments and clarifications received from the Secretariat of the World Trade Organization. The views expressed are solely the responsibility of the authors as with all WHO documents by named authors. This revision also contains speeches which were presented at the WHO Executive Board ad hoc working group on the Revised Drug Strategy, held in Geneva on 13 October 1998. The section on definitions and terminology has been updated. The bibliography and other reference material remain as in the original.
First edition November 1997
Second edition January 1999
© World Health Organization 1999
This document is not a formal publication of the World Health Organization (WHO), and all rights are reserved by the Organization. The document may, however, be freely reviewed, abstracted, reproduced and translated, in part or in whole, but not for sale nor for use in conjunction with commercial purposes.
The views expressed in documents by named authors are solely the responsibility of those authors.